Loren E. Clarke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Loren E. Clarke has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Klaus F. Helm
The Departments of Pathology The Penn State Hershey Medical Center Hershey PA, USA
4 shared publicationsJeannie Hennessy
3 shared publicationsJennie T. Clarke
2 shared publicationsLorraine Rosamilia
From the Departments of *Dermatology and †Pathology, The Penn State Hershey Medical Center, Hershey, PA
2 shared publications- Richard Bruggeman
University of Groningen
2 shared publications - Rogerio Izar Neves
Penn State Hershey Cancer Institute, Hershey, PA
2 shared publications
Latest Publications
- 1 October 2013
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 132, 42-43
Melanoma Incidence in Shaved Pigmented Lesions
- 1 October 2013
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 132, 42-43
Melanoma Incidence in Shaved Pigmented Lesions
- 17 April 2013
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (7) , 646-650
Expression of CK7, Cam 5.2 and Ber‐Ep4 in cutaneous squamous cell carcinoma
Cytokeratin 7 (CK7) and Cam 5.2 are often used to differentiate extramammary Paget's disease (EPD) from squamous cell carcinoma (SCC) in situ because they are generally considered to be expressed in the former but not in the latter. However, we have encountered CK7+ and Cam 5.2+ SCCs. We evaluated CK7, Cam 5.2 and Ber-Ep4 expression in SCC and EPD. We found significant CK7 and Cam 5.2 positivity in SCCs, particularly in those with a pagetoid pattern. Only one case expressed Ber-Ep4. We conclude that CK7 and Cam 5.2 expression may occur in SCC. A panel including Ber-Ep4 is advisable for immunohistochemical differentiation of EPD from SCC.
- 17 April 2013
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (7) , 646-650
Expression of CK7, Cam 5.2 and Ber‐Ep4 in cutaneous squamous cell carcinoma
Cytokeratin 7 (CK7) and Cam 5.2 are often used to differentiate extramammary Paget's disease (EPD) from squamous cell carcinoma (SCC) in situ because they are generally considered to be expressed in the former but not in the latter. However, we have encountered CK7+ and Cam 5.2+ SCCs. We evaluated CK7, Cam 5.2 and Ber-Ep4 expression in SCC and EPD. We found significant CK7 and Cam 5.2 positivity in SCCs, particularly in those with a pagetoid pattern. Only one case expressed Ber-Ep4. We conclude that CK7 and Cam 5.2 expression may occur in SCC. A panel including Ber-Ep4 is advisable for immunohistochemical differentiation of EPD from SCC.
- 1 October 2012
- Published by Elsevier in Dermatologic Clinics
- Vol. 30 (4) , 643-656
Fibrous and Fibrohistiocytic Neoplasms
- 1 October 2012
- Published by Elsevier in Dermatologic Clinics
- Vol. 30 (4) , 643-656
Fibrous and Fibrohistiocytic Neoplasms
- 1 January 2012
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 66 (1) , 98-105
Dermal dendritic cells in psoriasis, nummular dermatitis, and normal-appearing skin
- 1 January 2012
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 66 (1) , 98-105
Dermal dendritic cells in psoriasis, nummular dermatitis, and normal-appearing skin
- 1 June 2011
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 31 (2) , 255-265
Dysplastic Nevi
- 1 June 2011
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 31 (2) , 255-265
Dysplastic Nevi
- 1 December 2010
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 32 (8) , 764-768
Cutaneous CD34+ Spindle Cell Neoplasms: Histopathologic Features Distinguish Spindle Cell Lipoma, Solitary Fibrous Tumor, and Dermatofibrosarcoma Protuberans
Spindle cell lipoma (SCL), dermatofibrosarcoma protuberans (DFSP), and solitary fibrous tumors (SFT) are cutaneous CD34+ spindle cell tumors that may exhibit histopathologic and immunophenotypic overlap. We sought ways to reliably distinguish among these lesions even in small or superficial biopsies. Ten morphologic characteristics were analyzed in a group of 5 SCLs, 6 cutaneous SFTs, and 12 DFSPs. SFT and DFSP exhibited extensive histopathologic overlap in small or partial biopsies. However, adnexal entrapment, defined as diffuse proliferation of tumor cells around pilosebaceous and eccrine structures with minimal disruption or expansion of the dermis, was a feature seen in 10 of the 12 DFSPs and in none of the SFTs or SCLs. Even when only superficial portions of a lesion were present, this feature was identifiable. Spindle cell lipomas posed little diagnostic difficulty, in part because excisional biopsies were performed in all cases of SCL. The number of samples included in the study is relatively small, in part due to the rarity of cutaneous solitary fibrous tumors. We conclude that careful attention to these histopathologic features enables reliable distinction among these tumors.
- 1 December 2010
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 32 (8) , 764-768
Cutaneous CD34+ Spindle Cell Neoplasms: Histopathologic Features Distinguish Spindle Cell Lipoma, Solitary Fibrous Tumor, and Dermatofibrosarcoma Protuberans
Spindle cell lipoma (SCL), dermatofibrosarcoma protuberans (DFSP), and solitary fibrous tumors (SFT) are cutaneous CD34+ spindle cell tumors that may exhibit histopathologic and immunophenotypic overlap. We sought ways to reliably distinguish among these lesions even in small or superficial biopsies. Ten morphologic characteristics were analyzed in a group of 5 SCLs, 6 cutaneous SFTs, and 12 DFSPs. SFT and DFSP exhibited extensive histopathologic overlap in small or partial biopsies. However, adnexal entrapment, defined as diffuse proliferation of tumor cells around pilosebaceous and eccrine structures with minimal disruption or expansion of the dermis, was a feature seen in 10 of the 12 DFSPs and in none of the SFTs or SCLs. Even when only superficial portions of a lesion were present, this feature was identifiable. Spindle cell lipomas posed little diagnostic difficulty, in part because excisional biopsies were performed in all cases of SCL. The number of samples included in the study is relatively small, in part due to the rarity of cutaneous solitary fibrous tumors. We conclude that careful attention to these histopathologic features enables reliable distinction among these tumors.
- 18 May 2010
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 37 (7) , 777-786
Multiple cutaneous monoclonal B‐cell proliferations as harbingers of systemic angioimmunoblastic T‐cell lymphoma
We describe a 66‐year‐old man initially diagnosed with primary cutaneous marginal zone B‐cell lymphoma who developed four additional monoclonal/monotypic B‐cell lymphoid proliferations and a systemic angioimmunoblastic T‐cell lymphoma over the course of 19 months. Through retrospective analysis, we identified the evolution of a T‐cell clone within the background of clinically and pathologically dominant cutaneous B‐cell tumors. In terms of clinical practice, this case supports that patients diagnosed with multiple clonal B‐cell proliferation need thorough investigation and close clinical follow up to identify a coexistent or evolving systemic lymphoma, in particular, peripheral T‐cell lymphomas of follicular T‐helper cell type, such as angioimmunoblastic T‐cell lymphoma. Biologically, this case offers unique insight into the interactions between B‐cell and T‐cell lineages in lymphoid neoplasia.Bayerl MG, Hennessy J, Ehmann WC, Bagg A, Rosamilia L, Clarke LE. Multiple cutaneous monoclonal B‐cell proliferations as harbingers of systemic angioimmunoblastic T‐cell lymphoma.
- 18 May 2010
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 37 (7) , 777-786
Multiple cutaneous monoclonal B‐cell proliferations as harbingers of systemic angioimmunoblastic T‐cell lymphoma
We describe a 66‐year‐old man initially diagnosed with primary cutaneous marginal zone B‐cell lymphoma who developed four additional monoclonal/monotypic B‐cell lymphoid proliferations and a systemic angioimmunoblastic T‐cell lymphoma over the course of 19 months. Through retrospective analysis, we identified the evolution of a T‐cell clone within the background of clinically and pathologically dominant cutaneous B‐cell tumors. In terms of clinical practice, this case supports that patients diagnosed with multiple clonal B‐cell proliferation need thorough investigation and close clinical follow up to identify a coexistent or evolving systemic lymphoma, in particular, peripheral T‐cell lymphomas of follicular T‐helper cell type, such as angioimmunoblastic T‐cell lymphoma. Biologically, this case offers unique insight into the interactions between B‐cell and T‐cell lineages in lymphoid neoplasia.Bayerl MG, Hennessy J, Ehmann WC, Bagg A, Rosamilia L, Clarke LE. Multiple cutaneous monoclonal B‐cell proliferations as harbingers of systemic angioimmunoblastic T‐cell lymphoma.
- 18 May 2010
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 37 (7) , 737-743
CD10‐positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma
CD10 is now commonly used to differentiate atypical fibroxanthoma (AFX) from melanoma, spindle cell and dedifferentiated variants of squamous cell carcinoma and leiomyosarcoma. However, we have encountered CD10‐positive tumors that mimicked AFX but proved to be myxofibrosarcomas. The purpose of this study was to evaluate CD10 expression in a wide range of mesenchymal neoplasms that may involve the skin using tissue microarrays. Our results indicate that in addition to AFX, CD10 expression is common in myxofibrosarcomas, undifferentiated pleomorphic sarcomas, dermatofibromas and dermatofibrosarcoma protuberans. Myxofibrosarcomas commonly present in the skin and may be difficult to distinguish from AFX on small biopsies and CD10 positivity may confound the diagnostic difficulty.Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF. CD10‐positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
- 18 May 2010
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 37 (7) , 737-743
CD10‐positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma
CD10 is now commonly used to differentiate atypical fibroxanthoma (AFX) from melanoma, spindle cell and dedifferentiated variants of squamous cell carcinoma and leiomyosarcoma. However, we have encountered CD10‐positive tumors that mimicked AFX but proved to be myxofibrosarcomas. The purpose of this study was to evaluate CD10 expression in a wide range of mesenchymal neoplasms that may involve the skin using tissue microarrays. Our results indicate that in addition to AFX, CD10 expression is common in myxofibrosarcomas, undifferentiated pleomorphic sarcomas, dermatofibromas and dermatofibrosarcoma protuberans. Myxofibrosarcomas commonly present in the skin and may be difficult to distinguish from AFX on small biopsies and CD10 positivity may confound the diagnostic difficulty.Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF. CD10‐positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
- 30 September 2009
- Published by Elsevier in Surgical Pathology Clinics
- Vol. 2 (3) , 447-456
Dysplastic Nevi
- 30 September 2009
- Published by Elsevier in Surgical Pathology Clinics
- Vol. 2 (3) , 447-456
Dysplastic Nevi
- 1 April 2009
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 35 (4) , 685-686
Keratoacanthomatous Hyperplasia in Response to a Tattoo
- 1 April 2009
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 35 (4) , 685-686
Keratoacanthomatous Hyperplasia in Response to a Tattoo